BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10169530)

  • 1. Considerations in pharmaceutical conversion: focus on antihistamines.
    Garbus SB; Moulton BW; Meltzer EO; Reich PR; Weinreb LF; Friedman JA; Orland BI
    Am J Manag Care; 1997 Apr; 3(4):617-30. PubMed ID: 10169530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cut pharmaceutical costs, but mind the legal dangers.
    Abood RR
    Manag Care; 1997 Aug; 6(8):47-8, 51-4. PubMed ID: 10170246
    [No Abstract]   [Full Text] [Related]  

  • 3. Managed care implications of the approval of generic or over-the-counter nonsedating antihistamines.
    Giaquinta D
    Manag Care Interface; 2002 Jun; 15(6):31-4. PubMed ID: 12087604
    [No Abstract]   [Full Text] [Related]  

  • 4. Utilization of generics: a managed care failure?
    Epstein D
    Manag Care; 1997 May; 6(5):85-7. PubMed ID: 10168639
    [No Abstract]   [Full Text] [Related]  

  • 5. The future of pain management in managed care.
    Lande SD; Loeser JD
    Manag Care Interface; 2001 May; 14(5):69-75. PubMed ID: 11385952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug utilization review in the managed care environment.
    Briesacher B; DuChane J
    Med Interface; 1995 Mar; 8(3):72-4, 76-8. PubMed ID: 10141391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective strategies for managing pharmacy benefits.
    Jacobson D
    Healthc Financ Manage; 2001 Mar; 55(3):41-2. PubMed ID: 11258270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liability relating to formularies and drug utilization management.
    Elden DL
    AAPPO J; 1991; 1(2):33-7, 43-6. PubMed ID: 10148900
    [No Abstract]   [Full Text] [Related]  

  • 9. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost.
    Fendrick AM; Smith DG; Chernew ME; Shah SN
    Am J Manag Care; 2001 Sep; 7(9):861-7. PubMed ID: 11570020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation.
    Motheral BR; Henderson R
    Am J Manag Care; 1999 Nov; 5(11):1383-94. PubMed ID: 10662412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic substitution of antihypertensive drugs: does it affect adherence?
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    Ann Pharmacother; 2006 Jan; 40(1):15-20. PubMed ID: 16303985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing prescription drug costs.
    Sica JM
    Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The costs of nonsedating antihistamine therapy for allergic rhinitis in managed care: an updated analysis.
    Liao E; Leahy M; Cummins G
    Am J Manag Care; 2001 Oct; 7(15 Suppl):S459-68. PubMed ID: 11680261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facing the next challenge of pharmaceutical care: patient noncompliance.
    Bloom DL
    Med Interface; 1996 Nov; 9(11):67-72. PubMed ID: 10162562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
    Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE
    Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nondialysis (home) medication utilization and cost in diabetic and nondiabetic hemodialysis patients.
    Manley HJ; Cannella CA
    Nephrol News Issues; 2005 Jan; 19(2):27-8, 33-4, 36-8. PubMed ID: 15717572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A descriptive analysis of the use and cost of new-generation antihistamines in the treatment of allergic rhinitis: a retrospective database analysis.
    Lee J; Cummins G; Okamoto L
    Am J Manag Care; 2001 May; 7(4 Suppl):S103-12. PubMed ID: 11392821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical practice management.
    Reed L
    J Am Optom Assoc; 1998 Apr; 69(4):241-54. PubMed ID: 9585664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating quality of life data into managed care formulary decisions: a case study with salmeterol.
    Bukstein DA
    Am J Manag Care; 1997 Nov; 3(11):1701-6. PubMed ID: 10178468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do consumers' attitudes predict prescription purchasing behavior?
    Nair KV
    Manag Care Interface; 2003 Jun; 16(6):22-7, 55. PubMed ID: 12841073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.